{"id":46354,"date":"2024-12-19T16:28:01","date_gmt":"2024-12-19T16:28:01","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&#038;p=46354"},"modified":"2024-12-19T16:28:01","modified_gmt":"2024-12-19T16:28:01","slug":"bar-karrer-advised-the-sellers-on-the-sale-of-kempf-und-pfaltz","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/bar-karrer-advised-the-sellers-on-the-sale-of-kempf-und-pfaltz\/","title":{"rendered":"B\u00e4r &#038; Karrer Advised the Sellers on the Sale of kempf und pfaltz"},"content":{"rendered":"<p>The shareholders of kempf und pfaltz histologische diagnostik ag (kempf und pfaltz), a highly specialised Swiss dermatopathology laboratory, have sold their shares to Unilabs, a leading diagnostic services provider.<!--more--><\/p>\n<p>B\u00e4r &amp; Karrer acted as legal advisor to the sellers in this transaction. The team was co-led by Christoph Neeracher and Philippe Seiler and included Patrick Zumsteg, Lazar Lepir, Yascha Fengler and David Mark (all M&amp;A) as well as Susanne Schreiber and Fabian Capt (both Tax).<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-46354","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/46354","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=46354"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}